Scandion Oncology A/S Annual Report 2018 published
Scandion Oncology A/S hereby publishes the Annual Report for 2018. The Annual Report 2018 is available on the company's website (www.scandiononcology.com).For further information regarding Scandion Oncology, please contact: Nils Brünner, CEO Phone: +45 26 14 47 08 E-mail: nb@scandiononcology.com www.scandiononcology.com Scandion Oncology A/S is a biotechnology company founded in 2017 for the purpose of addressing and tackling one of the greatest challenges in modern oncology – the effective treatment of cancer which contains drug resistant cell clones or which has developed